SS Innovations International (SSII) Net Equity Issued and Repurchased (2016 - 2017)

SS Innovations International (SSII) reported Net Equity Issued and Repurchased of $81185.0 for Q4 2017, up 13660.17% on a YoY basis from N/an in Q4 2016, and down 82.39% sequentially from $461075.0 in Q3 2017.

SS Innovations International (SSII) Net Equity Issued and Repurchased (2016 - 2017) Analysis & Trends

SS Innovations International (SSII) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $81185.0 in Q4 2017.

  • For the quarter ending Q4 2017, Net Equity Issued and Repurchased rose 13660.17% year-over-year to $81185.0; the trailing twelve-month figure through Dec 2018 stood at $542260.0 (down 19.93% YoY), and the FY2023 full-year result was $412056.0, changed N/A from the prior year.
  • Net Equity Issued and Repurchased declined to $81185.0 in Q4 2017, from $461075.0 in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $461075.0 in Q3 2017 to a low of $590.0 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 97.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 12.70 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn -
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 SS Innovations International 699.75 Mn 676.14 Mn 5.33 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2017 81,185.00
Dec 31, 2017 81,185.00
Sep 30, 2017 461,075.00
Sep 30, 2017 461,075.00
Mar 31, 2017 135,000.00
Mar 31, 2017 135,000.00
Dec 31, 2016 590.00
Dec 31, 2016 590.00